Literature DB >> 16021172

The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis.

Natalija Novak1, Thomas Bieber.   

Abstract

BACKGROUND: Atopic dermatitis (AD) is an inflammatory, immunologically mediated skin disease characterized by a T helper type 2 cell-predominant phenotype initially with additional acquisition of T helper type 1 cell phenotype during the chronic eczematous phase. Compelling evidence presented here suggests that two types of dendritic cells (DC), myeloid DC (mDC) and plasmacytoid DC (pDC), are important in the pathogenesis of AD.
METHODS: We reviewed the current literature and summarized key information about the role of mDC and pDC in the pathogenesis of AD.
RESULTS: Langerhans cells and inflammatory dendritic epidermal cells, which bear the high-affinity receptor for immunoglobulin E on their cell surface, are hypothesized to contribute to the pathogenesis of AD. pDC, Which play an important role in the defence against viral infections, have also been shown to express high-affinity receptor for immunoglobulin E.
CONCLUSION: Immunoglobulin E receptor-bearing mDC and pDC subtypes in the blood and the skin of patients with AD are of critical immunologic importance in the complex pathophysiologic network of AD. Targeting mDC and pDC subtypes may lead to effective new therapies for the management of AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16021172     DOI: 10.1016/j.jaad.2005.04.060

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  28 in total

1.  Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges.

Authors:  Mao-Qiang Man; Yutaka Hatano; Seung H Lee; Mona Man; Sandra Chang; Kenneth R Feingold; Donald Y M Leung; Walter Holleran; Yoshikazu Uchida; Peter M Elias
Journal:  J Invest Dermatol       Date:  2007-08-02       Impact factor: 8.551

2.  Repair and maintenance of the epidermal barrier in patients diagnosed with atopic dermatitis: an evaluation of the components of a body wash-moisturizer skin care regimen directed at management of atopic skin.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2011-06

3.  Oral administration of Vaccinium uliginosum L. extract alleviates DNCB-induced atopic dermatitis in NC/Nga mice.

Authors:  Kang-Hyun Kim; Se-Young Choung
Journal:  J Med Food       Date:  2014-12       Impact factor: 2.786

4.  Characterization of canine dendritic cells in healthy, atopic, and non-allergic inflamed skin.

Authors:  Meret Elisabeth Ricklin; Petra Roosje; Artur Summerfield
Journal:  J Clin Immunol       Date:  2010-07-31       Impact factor: 8.317

5.  Atopic dermatitis.

Authors:  Thomas Bieber
Journal:  Ann Dermatol       Date:  2010-05-17       Impact factor: 1.444

Review 6.  Molecular biology of atopic dermatitis.

Authors:  Zhanglei Mu; Yan Zhao; Xiaojing Liu; Christopher Chang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 7.  Animal models of atopic dermatitis.

Authors:  Haoli Jin; Rui He; Michiko Oyoshi; Raif S Geha
Journal:  J Invest Dermatol       Date:  2009-01       Impact factor: 8.551

Review 8.  Resident and "inflammatory" dendritic cells in human skin.

Authors:  Lisa C Zaba; James G Krueger; Michelle A Lowes
Journal:  J Invest Dermatol       Date:  2008-08-14       Impact factor: 8.551

Review 9.  Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer.

Authors:  Julie Charles; Laurence Chaperot; Dimitri Salameire; Jérémy Di Domizio; Caroline Aspord; Rémy Gressin; Marie-Christine Jacob; Marie-Jeanne Richard; Jean-Claude Beani; Joel Plumas; Marie-Thérèse Leccia
Journal:  Eur J Dermatol       Date:  2009-10-22       Impact factor: 3.328

10.  Pollen allergens do not come alone: pollen associated lipid mediators (PALMS) shift the human immune systems towards a T(H)2-dominated response.

Authors:  Stefanie Gilles; Valentina Mariani; Martina Bryce; Martin J Mueller; Johannes Ring; Heidrun Behrendt; Thilo Jakob; Claudia Traidl-Hoffmann
Journal:  Allergy Asthma Clin Immunol       Date:  2009-10-22       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.